Effects of Buprenorphine and naloxone (BEMA Buprenorphine NX) in opioid dependent subjects.
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 09 May 2017
At a glance
- Drugs Buprenorphine/naloxone (Primary)
- Indications Drug dependence
- Focus Therapeutic Use
- Sponsors BioDelivery Sciences International
- 02 Feb 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 04 Nov 2014 New trial record